Investors
Information Disclosure
-
SHARE PURCHASE PLAN2022.03.31
-
FINAL DIVIDEND FOR 20212022.03.31
-
VOLUNTARY ANNOUNCEMENT CATEGORY I ANTI-TUMOUR INNOVATIVE MEDICINE FHND5071 OBTAINED APPROVAL FOR CLINICAL TRIAL2022.03.29
-
VOLUNTARY ANNOUNCEMENT - “METHACHOLINE CHLORIDE POWDER FOR SOLUTION, FOR INHALATION” OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.28
-
NEXT DAY DISCLOSURE RETURN2022.03.21
-
VOLUNTARY ANNOUNCEMENT - ENTERING INTO STRATEGIC COOPERATION2022.03.18
-
VOLUNTARY ANNOUNCEMENT - “MIRABEGRON SUSTAINED-RELEASE TABLETS” OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.17
-
VOLUNTARY ANNOUNCEMENT - “LINEZOLID TABLETS” OBTAINED DRUG REGISTRATION CERTIFICATE2022.03.16